Dana Investment Advisors Inc. Increases Stock Position in Phibro Animal Health Co. (NASDAQ:PAHC)

Dana Investment Advisors Inc. grew its stake in Phibro Animal Health Co. (NASDAQ:PAHC) by 17.2% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 513,926 shares of the company’s stock after acquiring an additional 75,546 shares during the period. Dana Investment Advisors Inc.’s holdings in Phibro Animal Health were worth $8,619,000 as of its most recent filing with the SEC.

Several other large investors have also recently made changes to their positions in the stock. Sofinnova Investments Inc. purchased a new stake in Phibro Animal Health in the second quarter valued at approximately $3,975,000. American Century Companies Inc. raised its holdings in shares of Phibro Animal Health by 119.6% in the 2nd quarter. American Century Companies Inc. now owns 347,191 shares of the company’s stock valued at $5,822,000 after buying an additional 189,068 shares during the period. Acadian Asset Management LLC lifted its stake in Phibro Animal Health by 32.8% during the 1st quarter. Acadian Asset Management LLC now owns 675,207 shares of the company’s stock worth $8,726,000 after acquiring an additional 166,776 shares in the last quarter. Wellington Management Group LLP boosted its holdings in Phibro Animal Health by 165.9% during the 4th quarter. Wellington Management Group LLP now owns 164,764 shares of the company’s stock valued at $1,908,000 after acquiring an additional 102,793 shares during the period. Finally, AXA S.A. acquired a new position in Phibro Animal Health in the 2nd quarter valued at about $906,000. 99.34% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Phibro Animal Health

In other news, Director E Thomas Corcoran acquired 5,000 shares of the firm’s stock in a transaction dated Wednesday, September 4th. The stock was acquired at an average cost of $20.02 per share, with a total value of $100,100.00. Following the completion of the acquisition, the director now owns 25,000 shares of the company’s stock, valued at $500,500. The acquisition was disclosed in a legal filing with the SEC, which is available through this link. 50.06% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

PAHC has been the topic of several research reports. JPMorgan Chase & Co. initiated coverage on shares of Phibro Animal Health in a research report on Tuesday, September 10th. They set a “neutral” rating and a $22.00 price target on the stock. Bank of America increased their target price on shares of Phibro Animal Health from $13.00 to $15.00 and gave the stock an “underperform” rating in a report on Friday, August 30th. Three equities research analysts have rated the stock with a sell rating, two have given a hold rating and one has given a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $15.00.

Phibro Animal Health Stock Up 2.0 %

PAHC stock opened at $22.52 on Tuesday. Phibro Animal Health Co. has a fifty-two week low of $9.40 and a fifty-two week high of $22.84. The company’s 50 day moving average price is $19.82 and its 200 day moving average price is $17.33. The company has a debt-to-equity ratio of 1.79, a quick ratio of 1.64 and a current ratio of 2.94. The firm has a market capitalization of $912.13 million, a price-to-earnings ratio of 70.38, a PEG ratio of 1.77 and a beta of 0.52.

Phibro Animal Health (NASDAQ:PAHC) last announced its quarterly earnings data on Wednesday, August 28th. The company reported $0.41 EPS for the quarter, beating analysts’ consensus estimates of $0.34 by $0.07. The company had revenue of $273.16 million for the quarter, compared to the consensus estimate of $262.44 million. Phibro Animal Health had a net margin of 0.24% and a return on equity of 18.08%. On average, equities research analysts anticipate that Phibro Animal Health Co. will post 1.44 EPS for the current fiscal year.

Phibro Animal Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, September 25th. Shareholders of record on Wednesday, September 4th were issued a dividend of $0.12 per share. The ex-dividend date of this dividend was Wednesday, September 4th. This represents a $0.48 dividend on an annualized basis and a yield of 2.13%. Phibro Animal Health’s payout ratio is currently 150.00%.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.